ALCAM and melanoma: ALCAM protein has been associated with prognosis in melanoma (van Kilsdonk et al, 2008), ovarian (Mezzanzanica et al, 2008), breast (Ihnen et al, 2010), prostate (Kristiansen et al, 2005), colorectal (Weichert et al, 2004), and pancreatic (Kahlert et al, 2009) cancers.